🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

WhiteHat Jr founder Karan Bajaj raises $16 Mn for new startup Complement1

EntrackrEntrackr · 8m ago
WhiteHat Jr founder Karan Bajaj raises $16 Mn for new startup Complement1
Medial

WhiteHat Jr founder Karan Bajaj raises $16 Mn for new startup Complement1 WhiteHat Jr was acquired by Byju’s for $300 million three years ago. At the time, its CEO Karan Bajaj went on to lead Byju’s Future School before leaving the company in August 2021. Karan Bajaj, the co-founder of Byju’s-owned WhiteHat Jr, has raised $16 million in seed funding for his new startup Complement1. The round was led by Owl Ventures and Blume Ventures, with participation from other undisclosed investors. Complement1 is a cancer care startup focusing on personalized lifestyle coaching in the United States. According to the company, it is emerging from stealth to launch the first tech-enabled, clinically validated lifestyle modification platform for cancer patients and high-risk individuals—delivering personalized, daily guidance and education through one-on-one dedicated CoActive Coaches. “Lifestyle change is one of the most powerful yet underused tools in cancer care,” said Karan Bajaj, CEO and co-founder of Complement 1. “Every oncologist will tell you patients need more support incorporating clinically recommended physical activity, nutrition and mind-body practices. We’ve cracked the code on daily engagement with personalized, compassionate coaching—helping patients make meaningful, lasting improvements during and beyond treatment.” With this fundraise, Complement 1 plans to scale up its coaching infrastructure and operations across the United States, advance its AI-driven personalization engine, and partner with cancer centers, health plans, and employers to bring the program to their cancer patients, high-risk individuals, and survivors. A part of this funding company will also go towards product development to enhance the digital user experience for both patients and coaches.

Tvaster Genkalp raises $1.25 Mn in pre-Series A round

EntrackrEntrackr · 10m ago
Tvaster Genkalp raises $1.25 Mn in pre-Series A round
Medial

Title: Tvaster Genkalp raises $1.25 Mn in pre-Series A round Healthtech startup Tvaster Genkalp has raised $1.25 million in its pre-Series A round led by Ideaspring Capital. Existing backers such as Invigo Softwares and liver transplant expert Prof. Mohamed Rela also joined the round. The proceeds will be used to help expand and market Episcreen™ Liver, a new blood test that can detect liver cancer early with 90% accuracy. This test offers a better option than the current standard, Alpha-Fetoprotein (AFP), which has only 50% sensitivity. Founded in 2021 by Dr. Srikar Raman and K. Sreedurgalakshmi, Tvaster is building high-accuracy, non-invasive tests for cancer. It aims to improve early detection and save lives, especially for liver cancer, which affects over 900,000 people globally every year. Tvaster has tested Episcreen™ Liver on over 600 patients and plans to partner with top diagnostic labs for wider access. The firm is also working on tests for bile duct cancer and childhood liver cancer treatment resistance. It recently won the ILTS Young Researcher Award and received a BIRAC BIG Grant for its work in cancer diagnostics.

Binny Bansal-backed RISA Labs raises $11.1 Mn in funding

EntrackrEntrackr · 23d ago
Binny Bansal-backed RISA Labs raises $11.1 Mn in funding
Medial

RISA Labs, an AI-driven healthtech startup, has raised $11.1 million in a funding round co-led by Cencora Ventures and Optum Ventures. The round also saw participation from Oncology Ventures, Z21 Ventures, and John Simon of Ventureforgood, along with existing backer Binny Bansal, co-founder of Flipkart. Earlier in April last year, RISA Labs had raised $3.5 million in a seed funding round led by Flipkart co-founder Binny Bansal and others. The proceeds will be used to scale product development, expand deployments with hospitals and cancer care networks, and support customer onboarding across the US healthcare system. Founded in the US, RISA Labs is building an AI operating system for cancer care. The platform focuses on automating clinical and administrative workflows in oncology, helping healthcare providers reduce manual effort, improve coordination, and speed up treatment processes. RISA Labs is targeting oncology providers that deal with complex workflows involving diagnostics, treatment planning, approvals, and patient coordination.

Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi

EntrackrEntrackr · 11d ago
Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi
Medial

Precision oncology startup 4baseCare has raised Rs 90 crore ($9.8 million) in the first close of its Series B round co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing investor Yali Capital. The new round comes after a gap of two years. In 2024, the company had raised $6 million in Series A funding, led by Yali Capital, with participation from Infosys. The fresh capital will be used to expand 4baseCare’s hospital-linked genomics lab network across India, the Middle East, Southeast Asia, Latin America, and Central Asia. It will also scale its AI-powered precision oncology platform, OncoTwin, which supports clinical decision-making for cancer treatment. Founded by Hitesh Goswami, 4baseCare focuses on building population-relevant clinico-genomic datasets to improve cancer diagnosis and treatment outcomes in underrepresented populations. Its platform integrates genomic testing with real-world clinical and outcomes data to generate actionable insights for oncologists. The OncoTwin platform was recently selected for the MSK iHub program at Memorial Sloan Kettering Cancer Center, New York. The company works closely with hospitals to offer genomics-led cancer diagnostics within clinical settings and is positioning itself to scale across emerging markets. Investor interest in cancer-focused startups has picked up in recent years. Last year, Everhope Oncology raised $10 million in seed funding, and MOC Cancer Care & Research Centre secured $18 million led by Elevation Capital. ErlySign, OnCare, and OneCell Diagnostics are also among the funded startups.

Download the medial app to read full posts, comements and news.